SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-011846
Filing Date
2019-08-08
Accepted
2019-08-08 09:16:37
Documents
80
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 547212
2 ex10-1.htm EX-10.1 205044
3 ex31-1.htm EX-31.1 15607
4 ex32-1.htm EX-32.1 7792
5 ex10-1_001.jpg GRAPHIC 8357
  Complete submission text file 0001493152-19-011846.txt   4433709

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xtnt-20190630.xml EX-101.INS 719447
7 XBRL SCHEMA FILE xtnt-20190630.xsd EX-101.SCH 56027
8 XBRL CALCULATION FILE xtnt-20190630_cal.xml EX-101.CAL 79223
9 XBRL DEFINITION FILE xtnt-20190630_def.xml EX-101.DEF 192017
10 XBRL LABEL FILE xtnt-20190630_lab.xml EX-101.LAB 395978
11 XBRL PRESENTATION FILE xtnt-20190630_pre.xml EX-101.PRE 314515
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 191007737
SIC: 2836 Biological Products, (No Diagnostic Substances)